These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 30223035)

  • 1. Modelling the in-vitro dissolution and release of sumatriptan succinate from polyvinylpyrrolidone-based microneedles.
    Ronnander P; Simon L; Spilgies H; Koch A
    Eur J Pharm Sci; 2018 Dec; 125():54-63. PubMed ID: 30223035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental and mathematical study of the transdermal delivery of sumatriptan succinate from polyvinylpyrrolidone-based microneedles.
    Ronnander P; Simon L; Koch A
    Eur J Pharm Biopharm; 2020 Jan; 146():32-40. PubMed ID: 31786322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissolving polyvinylpyrrolidone-based microneedle systems for in-vitro delivery of sumatriptan succinate.
    Ronnander P; Simon L; Spilgies H; Koch A; Scherr S
    Eur J Pharm Sci; 2018 Mar; 114():84-92. PubMed ID: 29203152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transdermal Delivery of Sumatriptan Succinate Using Iontophoresis and Dissolving Microneedles.
    Ronnander JP; Simon L; Koch A
    J Pharm Sci; 2019 Nov; 108(11):3649-3656. PubMed ID: 31374318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modelling of dissolving microneedles for transdermal drug delivery: theoretical and experimental aspects.
    Kim KS; Ita K; Simon L
    Eur J Pharm Sci; 2015 Feb; 68():137-43. PubMed ID: 25513710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of transdermal delivery of sumatriptan succinate using a novel self-dissolving microneedle array fabricated from sodium hyaluronate in rats.
    Wu D; Quan YS; Kamiyama F; Kusamori K; Katsumi H; Sakane T; Yamamoto A
    Biol Pharm Bull; 2015; 38(3):365-73. PubMed ID: 25757917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Permeation of sumatriptan succinate across human skin using multiple types of self-dissolving microneedle arrays fabricated from sodium hyaluronate.
    Wu D; Katsumi H; Quan YS; Kamiyama F; Kusamori K; Sakane T; Yamamoto A
    J Drug Target; 2016 Sep; 24(8):752-8. PubMed ID: 26878569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapidly dissolving polymeric microneedles for minimally invasive intraocular drug delivery.
    Thakur RR; Tekko IA; Al-Shammari F; Ali AA; McCarthy H; Donnelly RF
    Drug Deliv Transl Res; 2016 Dec; 6(6):800-815. PubMed ID: 27709355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sumatriptan succinate transdermal delivery systems for the treatment of migraine.
    Balaguer-Fernández C; Femenía-Font A; Del Rio-Sancho S; Merino V; López-Castellano A
    J Pharm Sci; 2008 Jun; 97(6):2102-9. PubMed ID: 17854062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling of Dissolving Microneedle-Based Transdermal Drug Delivery: Effects of Dynamics of Polymers in Solution.
    Yadav PR; Hingonia P; Das DB; Pattanayek SK
    Mol Pharm; 2024 Oct; 21(10):5104-5114. PubMed ID: 39259772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined use of biocompatible nanoemulsions and solid microneedles to improve transport of a model NSAID across the skin: In vitro and in vivo studies.
    Ilić T; Savić S; Batinić B; Marković B; Schmidberger M; Lunter D; Savić M; Savić S
    Eur J Pharm Sci; 2018 Dec; 125():110-119. PubMed ID: 30287408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vitro Skin Permeation Enhancement of Sumatriptan by Microneedle Application.
    Nalluri BN; Anusha SS; Bramhini SR; Amulya J; Sultana AS; Teja CU; Das DB
    Curr Drug Deliv; 2015; 12(6):761-9. PubMed ID: 25739035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioceramic microneedles with flexible and self-swelling substrate.
    Cai B; Xia W; Bredenberg S; Li H; Engqvist H
    Eur J Pharm Biopharm; 2015 Aug; 94():404-10. PubMed ID: 26126420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corneal delivery of besifloxacin using rapidly dissolving polymeric microneedles.
    Bhatnagar S; Saju A; Cheerla KD; Gade SK; Garg P; Venuganti VVK
    Drug Deliv Transl Res; 2018 Jun; 8(3):473-483. PubMed ID: 29288357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo evaluation of the transdermal iontophoretic delivery of sumatriptan succinate.
    Patel SR; Zhong H; Sharma A; Kalia YN
    Eur J Pharm Biopharm; 2007 May; 66(2):296-301. PubMed ID: 17182233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fabrication, characterization and application of sugar microneedles for transdermal drug delivery.
    Nguyen HX; Banga AK
    Ther Deliv; 2017 Mar; 8(5):249-264. PubMed ID: 28361607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of chemical enhancers on the in vitro percutaneous absorption of sumatriptan succinate.
    Femenía-Font A; Balaguer-Fernández C; Merino V; Rodilla V; López-Castellano A
    Eur J Pharm Biopharm; 2005 Sep; 61(1-2):50-5. PubMed ID: 15925502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transdermal Delivery of Functional Collagen Via Polyvinylpyrrolidone Microneedles.
    Sun W; Inayathullah M; Manoukian MA; Malkovskiy AV; Manickam S; Marinkovich MP; Lane AT; Tayebi L; Seifalian AM; Rajadas J
    Ann Biomed Eng; 2015 Dec; 43(12):2978-90. PubMed ID: 26066056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HPMC/PVP Dissolving Microneedles: a Promising Delivery Platform to Promote Trans-Epidermal Delivery of Alpha-Arbutin for Skin Lightening.
    Aung NN; Ngawhirunpat T; Rojanarata T; Patrojanasophon P; Opanasopit P; Pamornpathomkul B
    AAPS PharmSciTech; 2019 Dec; 21(1):25. PubMed ID: 31848807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coating formulations for microneedles.
    Gill HS; Prausnitz MR
    Pharm Res; 2007 Jul; 24(7):1369-80. PubMed ID: 17385011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.